18 posts in the category “Drug Safety”

A PatientsLikeMe researcher’s take on the opioid crisis and new prescribing regulations

Posted January 25th, 2017 by

Meet Emily (EmilyMcNaughton), a PatientsLikeMe researcher with more than ten years of experience in both the private and public sector. She’s here to weigh in on the recent Boston Globe article addressing the aftermath of the opioid crisis. New prescribing regulations have some doctors hesitant to prescribe these drugs, but that could prove more harmful to the patients who rely on them for pain control.

Check out the Boston Globe article, and see what Emily has to say below.

 

A researcher’s perspective

Prescription opioid medications have been widely discussed over the past 15 years, especially with the surge of prescriptions dispensed during the 2000s, which created an epidemic of abuse and overdose-related deaths. Because the prescription-opioid landscape seems to be constantly changing, people all across the medical, public health, regulatory and pharmaceutical sectors have been working to find solutions that will still allow patients to access their prescribed pain medications while minimizing problems with abuse, misuse, death, and product diversion (when patients either share, give or sell their prescription medications, or medications are stolen).

Many would agree that it’s been helpful to increase awareness, education and open communication between doctors and patients about these medications, but some aspects of restricting the availability of prescription opioids might cause unintended harm to patients.  As this Boston Globe article highlights, many doctors are now prescribing fewer opioids than in previous years and in some cases doctors fear that these reductions may hurt patients.

With any public health problem, solutions are not always perfect and there are pros and cons to every decision. In terms of prescription opioid medication, here are some of my thoughts on public health recommendations, regulatory changes and how they might impact patients. 

Advantages

  • There’s more awareness around how to appropriately use prescription opioids, the potential risks they pose and the proper prescribing practices, both within the medical community as well as patients and the public.
  • We’re seeing recommendations for increased patient-doctor communication about goals for prescription opioid use as well as alternative treatments, when appropriate.

Potential Unintended Consequences

  • There’s a growing pressure among doctors who fear there may be consequences for prescribing opioid medications.
  • There’s a possibility that difficult regulatory hurdles might deter a physician’s willingness, or even ability, to prescribe opioid medications in appropriate situations.
  • Blanket regulations that set maximum prescribing limits do not take into account the individual needs of each patient or doctor expertise.
  • Patients might have insufficient access to or may be unable to afford alternative treatments or pain medicine specialists if a physician is reluctant to prescribe opioid medications.

Other Considerations

  • Regulatory changes don’t address the issue of opioid-deaths that are caused by abuse of non-pharmaceutical products, like heroin.
  • For individuals with opioid addiction, substance abuse treatment remains complicated and is not always affordable.

What do you think about this topic?

 

Share this post on Twitter and help spread the word.


Improving drug safety through the patient voice

Posted November 22nd, 2013 by

At PatientsLikeMe we’re interested in bringing the voice of our patients to the attention of those who make drug products and to the regulators that approve them. Since 2008 we have conducted a series of projects to collect safety information from some of our member communities. We’ve worked with our pharmaceutical partners to help them better understand the safety experiences of patients while they are using certain drug products.

I’d like to introduce you to a new acronym – P.R.O.S.P.E.R.  It stands for Patient-Reported Outcomes in Safety Event Reporting and it promotes the value of including patient experiences in monitoring the safety of drug products during clinical trials and after drugs are approved.

The PROSPER Consortium is co-led and supported by PatientsLikeMe and Pope Woodhead, a UK healthcare firm, with input from most global pharmaceutical companies, many clinical and academic groups, as well as regulators, researchers and patient advocates.

A report from the Consortium was recently published in the journal Drug Safety that provides guidance for using patient reported outcomes (PROs) for safety monitoring processes. These are just a few of the reports findings…

  • The patient perspective is an essential component of drug safety
  • Patient-centeredness and patient safety are emerging as core elements of any responsive health system
  • The potential clinical utility and value of real-world information obtained from real patients taking real drugs is great1

Although the U.S. Food and Drug Administration (FDA) has accepted safety reports from consumers for 20 years through its MedWatch program, other parts of the world only accept reports on adverse reactions to drugs from health professionals. While patient reporting has recently been encouraged there remain skeptics who doubt its value.

PatientsLikeMe is part of the PROSPER Consortium because we believe the patient voice – your voice – is essential to improving the safety of drugs and medical products. As we look ahead to 2014, we’ll be exploring opportunities to amplify your voice across all areas of health care to improve safety, starting with the FDA and the EU counterpart, the European Medicines Agency.

PatientsLikeMe member MollyCotter


1 http://link.springer.com/article/10.1007/s40264-013-0113-z/fulltext.html